The Q-T interval and antimuscarinic drugs
Abstractnbsp;nbsp;Antimuscarinic drugs form the mainstay of pharmacotherapy for the treatment of overactive bladder. The primary sites of activity
of the agents for the desired therapeutic effect are the M3 and M2 receptors of the bladder. Drug interaction with other non-vesical
muscarinic receptors produces a range of undesired adverse events. In general, certain adverse effects associated with antimuscarinic
agents such as dry mouth (salivary) and constipation (colon) may be considered only bothersome, and somnolence and confusion
(central nervous system) may be considered more serious in nature. However, effects on the myocardium are considered to be
more significant safety issues and increased awareness and understanding of the effect of drugs on the myocardium, including
the a...
Soy supplement shows no blood pressure benefit
NEW YORK (Reuters Health) - Soy-rich diets have been linked to lower rates of heart disease, but a small study suggests that soy supplements may not do anything for older women's blood pressure. (Source: Reuters: Health)